View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Quest Diagnostics Inc: 1 director

A director at Quest Diagnostics Inc sold 1,748 shares at 175.515USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Labcorp Holdings Inc: 1 director

A director at Labcorp Holdings Inc sold 6,105 shares at 248.730USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 and Nasdaq 100 Testing Prior 2022 Highs Since late-February (2/25/25 Compass) we expected an 8-10% pullback to provide a buying opportunity. But that all changed in last week's Compass (4/1/25), when we downgraded our outlook to bearish/cautious, citing several concerning developments (SPX and QQQ failure at 200-day MAs, bear flag breakdowns across major indexes targeting 5100-5200 on SPX, high yield spreads widening above 355bps, major tops on market leaders NVDA and META, semiconducto...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Quest Diagnostics Incorporated and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 3 April 2025 in which we reassessed the appropriateness of the ratings in th...

Moody's Ratings affirms Laboratory Corporation of America's Baa2 backe...

Moody's Ratings (Moody's) affirmed Laboratory Corporation of America Holdings' ("Labcorp") Baa2 backed senior unsecured debt rating. At the same time, we revised the outlook to stable from positive. The revision of outlook reflects our expectation of the company's continued acquisition-led busines...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Moody's Ratings assigns Baa2 rating to Laboratory Corporation of Ameri...

Moody's Ratings (Moodys) assigned a Baa2 rating to Laboratory Corporation of America Holdings' ("Labcorp") proposed offering of backed senior unsecured notes of up to $1.8 billion. Labcorp intends to use the net proceeds from this offering, along with drawings from a new accounts receivables (A/R) s...

Moody's Ratings assigns Baa1 rating to Quest Diagnostics Incorporated'...

Moody's Ratings (Moodys) assigned a Baa1 rating to Quest Diagnostics Incorporated' ("Quest") proposed offering of senior unsecured notes. Quest intends to use the net proceeds from this offering to fund the recently announced acquisition of LifeLabs (a Canadian provider of community laboratory tests...

Laboratory Corporation of America Holdings: Update to credit analysis

Our credit view of this issuer reflects its significant scale and strong market position, against its low organic volume growth in a mature industry.

Laboratory Corporation of America Holdings: Update to credit analysis

Our credit view of this issuer reflects its significant scale and strong market position, against its low organic volume growth in a mature industry.

Quest Diagnostics Incorporated: Update to credit analysis

Our credit view of this issuer reflects its considerable scale and low financial leverage, constrained by its history of shareholder-friendly policies.

Moody's Ratings revises Laboratory Corporation of America's outlook to...

Moody's Ratings (Moody's) affirmed Laboratory Corporation of America Holdings' ("Labcorp") Baa2 senior unsecured debt ratings. At the same time, Moody's revised the outlook to positive from stable. The revision of outlook to positive reflects Moody's expectation that the company will continue its ...

Moody's Ratings upgrades Quest Diagnostics' senior unsecured debt rati...

Moody's Ratings (Moody's) upgraded the senior unsecured debt ratings of Quest Diagnostics Incorporated ("Quest") to Baa1 from Baa2. Moody's also upgraded the rating on the company's senior unsecured shelf registration to (P)Baa1 from (P) Baa2. The outlook was changed to stable from positive.        ...

Moody's assigns Baa2 rating to Quest Diagnostics' notes offering; posi...

Moody's Investors Service ("Moody's") assigned a Baa2 rating to the proposed offering of senior unsecured notes of Quest Diagnostics Incorporated ("Quest"). There are no changes to Moody's existing ratings of Quest including the Baa2 senior unsecured long-term ratings. The outlook remains unchanged ...

Laboratory Corporation of America Holdings: Update to credit analysis

Our credit view of this issuer reflects its good customer and geographic diversification and its stable cash flow, against its pricing pressures in core testing business.

Quest Diagnostics Incorporated: Update of our credit view following re...

Our credit view of this issuer reflects its considerable scale and low financial leverage, offset by its significant cash deployed to shareholders.

Moody's affirms Quest Diagnostics Incorporated at Baa2; revises outloo...

Moody's Investors Service ("Moody's") affirmed the senior unsecured ratings of Quest Diagnostics Incorporated ("Quest") at Baa2. At the same time, Moody's revised the outlook to positive from stable. The revision in outlook to positive reflects Moody's expectation for solid operating performance w...

 PRESS RELEASE

Labcorp Announces 2022 Third Quarter Results

BURLINGTON, N.C.--(BUSINESS WIRE)-- Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022, and updated full-year guidance. "Labcorp made important strategic progress this quarter and is well positioned to deliver sustained value and growth,” said Adam Schechter, chairman and CEO of Labcorp. “We are focusing on science, innovation and technology to serve our customers' needs. Our Diagnostics Base Business performed well, and our Drug Development Base Business fundamentals remain strong, despite challenging year-over-year ...

Laboratory Corporation of America Holdings: Update to credit analysis ...

Our credit view of this issuer reflects its low financial leverage and stable cash flow, constrained by pricing pressures in the core lab business.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch